Quantcast

Latest Regenerative biomedicine Stories

2010-11-04 09:02:00

LA JOLLA, Calif., Nov. 4, 2010 /PRNewswire/ -- Although demand and interest in adult stem cell therapies is increasing, it has been challenging for physicians, patients and policy-makers to retrieve the most current and accurate information available. Cell Society is an international nonprofit organization dedicated to the advancement of the clinical applications of adult stem cell regenerative therapies through the cooperation of patients, their physicians and world thought leaders. Cell...

2010-11-02 08:15:00

NEW YORK, Nov. 2, 2010 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Weihai Municipal Price Bureau, the local authority in charge of pricing for public medical services in China, approved the pricing for single side and bilateral arthroscopic orthopedic autologous adult stem cell based treatment being administered at Wendeng Orthopedic Hospital ("Wendeng...

2010-10-22 00:00:39

ReGen BioSciences Inc. announed today that Robert J. Sexauer is joining the Company as its new President. ReGen BioSciences is pioneering a new series of medical treatments in regenerative medicine by using a patient's own adult stem cells. New York, NY (PRWEB) October 21, 2010 PRWEB) October 21, 2010 -- ReGen BioSciences Inc. announed today that Robert J. Sexauer is joining the Company as its new President. ReGen BioSciences is pioneering a new series of medical treatments in...

2010-09-01 14:00:00

NEW YORK, Sept. 1 /PRNewswire/ -- TriMark Publications, LLC (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014. Regenerative medicine is a technique to treat injuries and diseases with specially-grown tissues by way of several...

2010-08-30 07:00:00

INDIANAPOLIS, Aug. 30 /PRNewswire/ -- Some of the most promising medical research conducted to treat diseases of the brain, heart, and circulatory system is moving too slowly to help millions of patients, according to the Cell Therapy Foundation, which advocates the use of adult stem cells to dramatically impact and improve the condition of patients who suffer from a variety of conditions. A Cell Therapy Foundation analysis of current clinical trials points to a critical need: more...

2010-08-26 14:14:00

SUNRISE, Fla., Aug. 26 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico. In March, Bioheart entered into an agreement to establish a Center of Excellence for the introduction of its therapies. Through...

2010-08-17 21:04:30

'Landmark work' moves beyond the bench Mayo Clinic investigators, with Belgian collaborators, have demonstrated that rationally "guided" human adult stem cells can effectively heal, repair and regenerate damaged heart tissue. The findings -- called "landmark work" in an accompanying editorial -- appear in today's Journal of the American College of Cardiology. Stem cells isolated from patients have normally a limited capacity to repair the heart. This innovative technology boosts the...

2010-08-13 14:16:26

The American Society of Hematology (ASH) has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine." Regenerative medicine is a multidisciplinary approach to treating diseases and disorders by...

2010-07-12 07:42:00

NEW YORK, July 12 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that it has been awarded a $700,000 contract from the U.S. Army Medical Research and Materiel Command, Telemedicine and Advanced Technology Research Center (USAMRMC-TATRC) under U.S. Army Medical Research Acquisition Activity contract number: (W81XWH-10-2-0039). This contract is for...

2010-07-01 08:04:00

AUSTIN, Texas, July 1 /PRNewswire/ -- SpineSmith Partners and Celling Technologies hired Brian Burkinshaw as Vice President of Research and Development, strengthening the company's position as an industry leader in adult stem cell technology innovations. Burkinshaw will lead SpineSmith's product development efforts through the collaboration of the company's mechanical engineering department and Celling Technologies' team of scientists. These teams work closely with surgeons to develop...


Latest Regenerative biomedicine Reference Libraries

The Axolotl, Ambystoma mexicanum
2014-02-03 08:59:54

Axolotl (Ambystoma mexicanum) may also be referred to as the Mexican salamander or the Mexican walking fish. The Axolotl is a member of the Ambystomatidae family and although its common name may suggest it is a fish, it is an amphibian. Axolotl are found exclusively in Mexico. The species situates, near Mexico City, on the bottom of Xochimilco’s lakes. Unlike most salamanders, Axolotl keep its larval features throughout its entire life and very rarely ever emerge from water. A condition...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related